Therapies

Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer

1 month ago   |   By Xconomy

Japanese drug giant Astellas Pharma announced late Monday it has agreed to buy Audentes Therapeutics, which is developing gene therapies for rare neuromuscular diseases. It's an all-cash deal worth $3 billion, with the Astellas offer of $60 per share representing a 110 percent premium to Audentes' share price of $28.61 apiece at market close Monday. The agreement is the latest big bet by a major pharmaceutical company on gene therapy, which aims to provide long-lasting, if not permanent, disease treatments. San Francisco-based Audentes' lead drug candidate, AT132, is a clinical-stage...
Read more ...

 

Astellas inks $3B Audentes buyout to expand in gene therapy

Astellas inks $3B Audentes buyout to expand in gene therapy

1 month ago   |   By Fierce Biotech

Astellas Pharma is set to buy Audentes Therapeutics for $3 billion. The deal will enable Astellas to set up a new genetic regulation unit spearheaded by a neuromuscular disease gene therapy that is set to be submitted for approval next year.
Read more ...

 


Search by Tags

   Therapies      Pharmaceutical      Pharma      Therapeutics      Drugs      Drug      Pharmaceuticals      Clinical      Gene      Genes      Gene Therapy      National      National blog main      National top stories      San Francisco blog main      San Francisco top stories      Acquisition      Antitrust      Astellas Pharma      Audentes      Big Pharma      Biotech      Buyout      Clinical trials      Deals      Drug Pricing      FDA      Joseph Schwartz      Life Sciences      M&A      Mergers      Neuromuscular disease      Orbimed      Rare disease      Regulatory review      Roche      Spark      Spark Therapeutics      Startup      SVB Leerink      Genetics  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug... Read more ...

Trending News on Crop Biotech in 2019

Trending News on Crop Biotech in 2019

We summarized the top 10 most trending Crop Biotech Update news shared on social media to give you a glimpse of crop biotech happenings in 2019. Read on and make sure you don't... Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new... Read more ...

Event Announcement: Xcelerating Life Sciences San Diego

Event Announcement: Xcelerating Life Sciences San Diego

We're excited to announce the first in Xconomy's new Xcelerating Life Sciences event series convening local communities of innovators, executives, rising pioneers... Read more ...

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference

Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development. Mayo... Read more ...

How Breast Cancer Reunited Six High School Friends

How Breast Cancer Reunited Six High School Friends

Four of the six of us from my high school inner circle have had breast cancer over the past two years. And that has me wondering. Did a shared environmental exposure, stamped... Read more ...

Stepping into their own

Stepping into their own

Two Bond Life Sciences Center researchers find their path in teaching and research Sarah Unruh and Vinit Shanbhag have both taken paths that have led them toward teaching... Read more ...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million in financing. The Series B round was led by... Read more ...

103395 Biorepository Assistant

CANCER CENTER/ Solid Tumor Therapeutics Salary commensurate with qualifications and experienceFiling Deadline: Fri 1/31/2020... Read more ...

Quantitative visualization of subcellular lignocellulose revealing the...

As a renewable carbon source, biomass energy not only helps in resolving the management problems of lignocellulosic wastes, but also helps to alleviate the global climate... Read more ...